4//SEC Filing
SCHLEIFER LEONARD S 4
Accession 0001883850-24-000022
CIK 0000872589other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:10 PM ET
Size
32.8 KB
Accession
0001883850-24-000022
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorCEO and President10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-13$399.66/sh+203,204$81,212,511→ 577,633 total - Sale
Common Stock
2024-05-14$979.16/sh−22,698$22,224,974→ 410,502 total - Sale
Common Stock
2024-05-15$980.64/sh−295$289,289→ 400,041 total - Sale
Common Stock
2024-05-15$982.66/sh−235$230,925→ 398,725 total - Sale
Common Stock
2024-05-15$981.50/sh−1,081$1,061,002→ 398,960 total - Tax Payment
Common Stock
2024-05-13$976.79/sh−144,433$141,080,710→ 433,200 total - Sale
Common Stock
2024-05-14$980.10/sh−2,302$2,256,190→ 408,200 total - Sale
Common Stock
2024-05-15$979.05/sh−7,864$7,699,249→ 400,336 total - Sale
Common Stock
2024-05-15$988.76/sh−299$295,639→ 397,259 total - Sale
Common Stock
2024-05-15$983.91/sh−250$245,978→ 398,475 total - Sale
Common Stock
2024-05-15$984.00/sh−305$300,120→ 398,170 total - Sale
Common Stock
2024-05-15$985.72/sh−281$276,987→ 397,889 total - Sale
Common Stock
2024-05-15$986.57/sh−103$101,617→ 397,786 total - Sale
Common Stock
2024-05-15$987.46/sh−228$225,141→ 397,558 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-05-13−203,204→ 0 totalExercise: $399.66Exp: 2024-12-16→ Common Stock (203,204 underlying)
Holdings
- 64,985(indirect: By Trust)
Common Stock
- 250,000(indirect: 2023 GRAT)
Common Stock
- 5,932(indirect: By 401(k))
Common Stock
Footnotes (14)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F10]Represents volume-weighted average price of sales of 281 shares of Company stock on May 15, 2024 at prices ranging from $985.13 to $985.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 103 shares of Company stock on May 15, 2024 at prices ranging from $986.37 to $986.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 228 shares of Company stock on May 15, 2024 at prices ranging from $987.31 to $987.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 299 shares of Company stock on May 15, 2024 at prices ranging from $988.00 to $988.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F14]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- [F2]Represents volume-weighted average price of sales of 22,698 shares of Company stock on May 14, 2024 at prices ranging from $979.00 to $979.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 2,302 shares of Company stock on May 14, 2024 at prices ranging from $980.00 to $980.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 7,864 shares of Company stock on May 15, 2024 at prices ranging from $979.00 to $979.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 295 shares of Company stock on May 15, 2024 at prices ranging from $980.17 to $980.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 1,081 shares of Company stock on May 15, 2024 at prices ranging from $981.09 to $981.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 235 shares of Company stock on May 15, 2024 at prices ranging from $982.31 to $982.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 250 shares of Company stock on May 15, 2024 at prices ranging from $983.82 to $983.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 305 shares of Company stock on May 15, 2024 at prices ranging from $984.00 to $984.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001218629
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:10 PM ET
- Size
- 32.8 KB